| Product Code: ETC13230700 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Acquired Angioedema Treatment Market was valued at USD 0.2 Billion in 2024 and is expected to reach USD 0.37 Billion by 2031, growing at a compound annual growth rate of 7.80% during the forecast period (2025-2031).
The Global Acquired Angioedema Treatment Market is witnessing growth due to increasing awareness about the condition and advancements in treatment options. Acquired angioedema is a rare disorder characterized by recurrent episodes of swelling in various body parts. The market is driven by the rising prevalence of angioedema, expanding healthcare infrastructure, and the development of novel therapies. Pharmaceutical companies are investing in research and development to introduce innovative treatments, such as C1 inhibitor replacement therapy and bradykinin receptor antagonists, which are expected to drive market growth. Moreover, the increasing adoption of biologics and targeted therapies is further fueling market expansion. Geographically, North America and Europe dominate the market, while emerging economies in Asia-Pacific and Latin America present lucrative opportunities for market players.
The Global Acquired Angioedema Treatment Market is witnessing a growing demand for novel therapeutic approaches and advancements in treatment options. There is a rising focus on developing targeted therapies that address the underlying causes of acquired angioedema, including the use of monoclonal antibodies and complement inhibitors. Additionally, the increasing awareness about this rare condition among healthcare professionals and patients is driving earlier diagnosis and treatment initiation. Market players are also exploring opportunities in expanding their product portfolios through strategic collaborations and acquisitions to cater to the unmet medical needs of patients with acquired angioedema. Overall, the market presents promising growth prospects fueled by ongoing research and development efforts aimed at improving patient outcomes and quality of life.
The Global Acquired Angioedema Treatment Market faces several challenges, including limited awareness about the condition among healthcare professionals and patients, leading to underdiagnosis and improper management. Additionally, the high cost of treatment options, such as C1 inhibitor replacement therapies, can pose a financial burden on patients and healthcare systems. The rarity of acquired angioedema compared to hereditary angioedema also presents challenges in conducting clinical trials and developing targeted therapies. Furthermore, the lack of standardized guidelines for the diagnosis and treatment of acquired angioedema can result in variability in patient care and outcomes. Overcoming these challenges will require increased education and awareness efforts, as well as continued research and development of more affordable and effective treatment options for acquired angioedema patients.
The global acquired angioedema treatment market is primarily driven by the increasing prevalence of angioedema disorders worldwide. Rising awareness about the condition among healthcare professionals and patients, along with improved diagnostic techniques, is also contributing to market growth. Additionally, advancements in treatment options such as novel therapies and targeted drug development are fueling the demand for effective therapies. Government initiatives and healthcare organizations focusing on rare diseases are further boosting market expansion. Furthermore, the growing research and development activities in the field of angioedema treatment, as well as collaborations between pharmaceutical companies and research institutions, are expected to drive innovation and enhance the overall market outlook for acquired angioedema treatment.
Government policies related to the Global Acquired Angioedema Treatment Market focus on regulating the approval and marketing of pharmaceutical products to ensure safety, efficacy, and quality. Policies include stringent approval processes by regulatory bodies such as the FDA in the United States and the EMA in Europe to assess the effectiveness and safety of treatments for acquired angioedema. Additionally, government policies often aim to promote research and development in the field of rare diseases, providing incentives for companies to invest in innovative treatments for this condition. These policies also support initiatives to improve access to treatment for patients, potentially including reimbursement programs or funding for clinical trials. Overall, government policies play a crucial role in shaping the landscape of the Global Acquired Angioedema Treatment Market by ensuring high standards of quality and patient safety.
The Global Acquired Angioedema Treatment Market is expected to witness significant growth in the coming years due to factors such as increasing awareness about this rare disease, advancements in treatment options, and a rising prevalence of angioedema cases worldwide. The market is likely to be driven by the development of novel therapies, expanding research and development activities, and collaborations between pharmaceutical companies and research institutions. Additionally, the growing healthcare infrastructure in emerging economies and the emphasis on early diagnosis and treatment are anticipated to further propel market growth. However, challenges such as high treatment costs and limited access to healthcare services in some regions may hinder market expansion to a certain extent. Overall, the Global Acquired Angioedema Treatment Market is poised for steady growth in the foreseeable future.
In the Global Acquired Angioedema Treatment Market, different regions exhibit varying trends. In Asia, the market is witnessing significant growth due to increasing awareness about the condition and improving healthcare infrastructure. North America dominates the market with a high prevalence of acquired angioedema cases and advanced treatment options. Europe follows closely behind, driven by the presence of key market players and ongoing research and development activities. The Middle East and Africa region is experiencing a gradual increase in market growth, facilitated by rising healthcare investments. Latin America shows potential for market expansion, supported by the increasing adoption of advanced treatment modalities. Overall, these regional insights indicate a promising outlook for the Global Acquired Angioedema Treatment Market across diverse geographical areas.
Global Acquired Angioedema Treatment Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Acquired Angioedema Treatment Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Acquired Angioedema Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Global Acquired Angioedema Treatment Market - Industry Life Cycle |
3.4 Global Acquired Angioedema Treatment Market - Porter's Five Forces |
3.5 Global Acquired Angioedema Treatment Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Acquired Angioedema Treatment Market Revenues & Volume Share, By Typeof Angioedema, 2021 & 2031F |
3.7 Global Acquired Angioedema Treatment Market Revenues & Volume Share, By Treatment Modalities, 2021 & 2031F |
3.8 Global Acquired Angioedema Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Global Acquired Angioedema Treatment Market Revenues & Volume Share, By End-User, 2021 & 2031F |
3.10 Global Acquired Angioedema Treatment Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.11 Global Acquired Angioedema Treatment Market Revenues & Volume Share, By Cause of Angioedema, 2021 & 2031F |
3.12 Global Acquired Angioedema Treatment Market Revenues & Volume Share, By Price Range, 2021 & 2031F |
3.13 Global Acquired Angioedema Treatment Market Revenues & Volume Share, By Brand, 2021 & 2031F |
4 Global Acquired Angioedema Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Acquired Angioedema Treatment Market Trends |
6 Global Acquired Angioedema Treatment Market, 2021 - 2031 |
6.1 Global Acquired Angioedema Treatment Market, Revenues & Volume, By Typeof Angioedema, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Acquired Angioedema Treatment Market, Revenues & Volume, By Hereditary Angioedema (HAE), 2021 - 2031 |
6.1.3 Global Acquired Angioedema Treatment Market, Revenues & Volume, By Acquired Angioedema, 2021 - 2031 |
6.2 Global Acquired Angioedema Treatment Market, Revenues & Volume, By Treatment Modalities, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Acquired Angioedema Treatment Market, Revenues & Volume, By Pharmacological Therapies, 2021 - 2031 |
6.2.3 Global Acquired Angioedema Treatment Market, Revenues & Volume, By C1 Inhibitors Replacement Therapy, 2021 - 2031 |
6.2.4 Global Acquired Angioedema Treatment Market, Revenues & Volume, By Bradykinin Receptor Antagonists, 2021 - 2031 |
6.3 Global Acquired Angioedema Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Acquired Angioedema Treatment Market, Revenues & Volume, By Oral Medications, 2021 - 2031 |
6.3.3 Global Acquired Angioedema Treatment Market, Revenues & Volume, By Injectable Therapies, 2021 - 2031 |
6.3.4 Global Acquired Angioedema Treatment Market, Revenues & Volume, By Topical Treatments, 2021 - 2031 |
6.4 Global Acquired Angioedema Treatment Market, Revenues & Volume, By End-User, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Acquired Angioedema Treatment Market, Revenues & Volume, By Hospitals and Clinics, 2021 - 2031 |
6.4.3 Global Acquired Angioedema Treatment Market, Revenues & Volume, By Homecare Settings, 2021 - 2031 |
6.4.4 Global Acquired Angioedema Treatment Market, Revenues & Volume, By Specialized Treatment Centers, 2021 - 2031 |
6.5 Global Acquired Angioedema Treatment Market, Revenues & Volume, By Age Group, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Acquired Angioedema Treatment Market, Revenues & Volume, By Pediatric Population, 2021 - 2031 |
6.5.3 Global Acquired Angioedema Treatment Market, Revenues & Volume, By Adult Population, 2021 - 2031 |
6.6 Global Acquired Angioedema Treatment Market, Revenues & Volume, By Cause of Angioedema, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 Global Acquired Angioedema Treatment Market, Revenues & Volume, By Allergic Angioedema, 2021 - 2031 |
6.6.3 Global Acquired Angioedema Treatment Market, Revenues & Volume, By Non-Allergic Angioedema, 2021 - 2031 |
6.7 Global Acquired Angioedema Treatment Market, Revenues & Volume, By Price Range, 2021 - 2031 |
6.7.1 Overview & Analysis |
6.7.2 Global Acquired Angioedema Treatment Market, Revenues & Volume, By Standard Therapies, 2021 - 2031 |
6.7.3 Global Acquired Angioedema Treatment Market, Revenues & Volume, By Specialty Therapies, 2021 - 2031 |
6.8 Global Acquired Angioedema Treatment Market, Revenues & Volume, By Brand, 2021 - 2031 |
6.8.1 Overview & Analysis |
6.8.2 Global Acquired Angioedema Treatment Market, Revenues & Volume, By Leading Brands, 2021 - 2031 |
6.8.3 Global Acquired Angioedema Treatment Market, Revenues & Volume, By Generic Options, 2021 - 2031 |
7 North America Acquired Angioedema Treatment Market, Overview & Analysis |
7.1 North America Acquired Angioedema Treatment Market Revenues & Volume, 2021 - 2031 |
7.2 North America Acquired Angioedema Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Acquired Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Acquired Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Acquired Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Acquired Angioedema Treatment Market, Revenues & Volume, By Typeof Angioedema, 2021 - 2031 |
7.4 North America Acquired Angioedema Treatment Market, Revenues & Volume, By Treatment Modalities, 2021 - 2031 |
7.5 North America Acquired Angioedema Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.6 North America Acquired Angioedema Treatment Market, Revenues & Volume, By End-User, 2021 - 2031 |
7.7 North America Acquired Angioedema Treatment Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.8 North America Acquired Angioedema Treatment Market, Revenues & Volume, By Cause of Angioedema, 2021 - 2031 |
7.9 North America Acquired Angioedema Treatment Market, Revenues & Volume, By Price Range, 2021 - 2031 |
7.10 North America Acquired Angioedema Treatment Market, Revenues & Volume, By Brand, 2021 - 2031 |
8 Latin America (LATAM) Acquired Angioedema Treatment Market, Overview & Analysis |
8.1 Latin America (LATAM) Acquired Angioedema Treatment Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Acquired Angioedema Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Acquired Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Acquired Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Acquired Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Acquired Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Acquired Angioedema Treatment Market, Revenues & Volume, By Typeof Angioedema, 2021 - 2031 |
8.4 Latin America (LATAM) Acquired Angioedema Treatment Market, Revenues & Volume, By Treatment Modalities, 2021 - 2031 |
8.5 Latin America (LATAM) Acquired Angioedema Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.6 Latin America (LATAM) Acquired Angioedema Treatment Market, Revenues & Volume, By End-User, 2021 - 2031 |
8.7 Latin America (LATAM) Acquired Angioedema Treatment Market, Revenues & Volume, By Age Group, 2021 - 2031 |
8.8 Latin America (LATAM) Acquired Angioedema Treatment Market, Revenues & Volume, By Cause of Angioedema, 2021 - 2031 |
8.9 Latin America (LATAM) Acquired Angioedema Treatment Market, Revenues & Volume, By Price Range, 2021 - 2031 |
8.10 Latin America (LATAM) Acquired Angioedema Treatment Market, Revenues & Volume, By Brand, 2021 - 2031 |
9 Asia Acquired Angioedema Treatment Market, Overview & Analysis |
9.1 Asia Acquired Angioedema Treatment Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Acquired Angioedema Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Acquired Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Acquired Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Acquired Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Acquired Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Acquired Angioedema Treatment Market, Revenues & Volume, By Typeof Angioedema, 2021 - 2031 |
9.4 Asia Acquired Angioedema Treatment Market, Revenues & Volume, By Treatment Modalities, 2021 - 2031 |
9.5 Asia Acquired Angioedema Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.6 Asia Acquired Angioedema Treatment Market, Revenues & Volume, By End-User, 2021 - 2031 |
9.7 Asia Acquired Angioedema Treatment Market, Revenues & Volume, By Age Group, 2021 - 2031 |
9.8 Asia Acquired Angioedema Treatment Market, Revenues & Volume, By Cause of Angioedema, 2021 - 2031 |
9.9 Asia Acquired Angioedema Treatment Market, Revenues & Volume, By Price Range, 2021 - 2031 |
9.10 Asia Acquired Angioedema Treatment Market, Revenues & Volume, By Brand, 2021 - 2031 |
10 Africa Acquired Angioedema Treatment Market, Overview & Analysis |
10.1 Africa Acquired Angioedema Treatment Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Acquired Angioedema Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Acquired Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Acquired Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Acquired Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Acquired Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Acquired Angioedema Treatment Market, Revenues & Volume, By Typeof Angioedema, 2021 - 2031 |
10.4 Africa Acquired Angioedema Treatment Market, Revenues & Volume, By Treatment Modalities, 2021 - 2031 |
10.5 Africa Acquired Angioedema Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.6 Africa Acquired Angioedema Treatment Market, Revenues & Volume, By End-User, 2021 - 2031 |
10.7 Africa Acquired Angioedema Treatment Market, Revenues & Volume, By Age Group, 2021 - 2031 |
10.8 Africa Acquired Angioedema Treatment Market, Revenues & Volume, By Cause of Angioedema, 2021 - 2031 |
10.9 Africa Acquired Angioedema Treatment Market, Revenues & Volume, By Price Range, 2021 - 2031 |
10.10 Africa Acquired Angioedema Treatment Market, Revenues & Volume, By Brand, 2021 - 2031 |
11 Europe Acquired Angioedema Treatment Market, Overview & Analysis |
11.1 Europe Acquired Angioedema Treatment Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Acquired Angioedema Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Acquired Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Acquired Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Acquired Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Acquired Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Acquired Angioedema Treatment Market, Revenues & Volume, By Typeof Angioedema, 2021 - 2031 |
11.4 Europe Acquired Angioedema Treatment Market, Revenues & Volume, By Treatment Modalities, 2021 - 2031 |
11.5 Europe Acquired Angioedema Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.6 Europe Acquired Angioedema Treatment Market, Revenues & Volume, By End-User, 2021 - 2031 |
11.7 Europe Acquired Angioedema Treatment Market, Revenues & Volume, By Age Group, 2021 - 2031 |
11.8 Europe Acquired Angioedema Treatment Market, Revenues & Volume, By Cause of Angioedema, 2021 - 2031 |
11.9 Europe Acquired Angioedema Treatment Market, Revenues & Volume, By Price Range, 2021 - 2031 |
11.10 Europe Acquired Angioedema Treatment Market, Revenues & Volume, By Brand, 2021 - 2031 |
12 Middle East Acquired Angioedema Treatment Market, Overview & Analysis |
12.1 Middle East Acquired Angioedema Treatment Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Acquired Angioedema Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Acquired Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Acquired Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Acquired Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Acquired Angioedema Treatment Market, Revenues & Volume, By Typeof Angioedema, 2021 - 2031 |
12.4 Middle East Acquired Angioedema Treatment Market, Revenues & Volume, By Treatment Modalities, 2021 - 2031 |
12.5 Middle East Acquired Angioedema Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.6 Middle East Acquired Angioedema Treatment Market, Revenues & Volume, By End-User, 2021 - 2031 |
12.7 Middle East Acquired Angioedema Treatment Market, Revenues & Volume, By Age Group, 2021 - 2031 |
12.8 Middle East Acquired Angioedema Treatment Market, Revenues & Volume, By Cause of Angioedema, 2021 - 2031 |
12.9 Middle East Acquired Angioedema Treatment Market, Revenues & Volume, By Price Range, 2021 - 2031 |
12.10 Middle East Acquired Angioedema Treatment Market, Revenues & Volume, By Brand, 2021 - 2031 |
13 Global Acquired Angioedema Treatment Market Key Performance Indicators |
14 Global Acquired Angioedema Treatment Market - Export/Import By Countries Assessment |
15 Global Acquired Angioedema Treatment Market - Opportunity Assessment |
15.1 Global Acquired Angioedema Treatment Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Acquired Angioedema Treatment Market Opportunity Assessment, By Typeof Angioedema, 2021 & 2031F |
15.3 Global Acquired Angioedema Treatment Market Opportunity Assessment, By Treatment Modalities, 2021 & 2031F |
15.4 Global Acquired Angioedema Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.5 Global Acquired Angioedema Treatment Market Opportunity Assessment, By End-User, 2021 & 2031F |
15.6 Global Acquired Angioedema Treatment Market Opportunity Assessment, By Age Group, 2021 & 2031F |
15.7 Global Acquired Angioedema Treatment Market Opportunity Assessment, By Cause of Angioedema, 2021 & 2031F |
15.8 Global Acquired Angioedema Treatment Market Opportunity Assessment, By Price Range, 2021 & 2031F |
15.9 Global Acquired Angioedema Treatment Market Opportunity Assessment, By Brand, 2021 & 2031F |
16 Global Acquired Angioedema Treatment Market - Competitive Landscape |
16.1 Global Acquired Angioedema Treatment Market Revenue Share, By Companies, 2024 |
16.2 Global Acquired Angioedema Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |